Former FDA director and deputy commissioner secures Senate approval.
The U.S. Senate has confirmed Scott Gottlieb, President Trump’s nominee to lead the Food and Drug Administration (FDA), by a 57-42 vote, according to a report by The Hill.
Gottlieb was an FDA director and deputy commissioner under former President George W. Bush. He will replace Robert Califf, the acting FDA chief who was appointed last year by former President Barack Obama.
Among other tasks, the FDA chief will be responsible for reviewing Obama administration regulations for electronic cigarettes and requirements for calorie counts on restaurant menus.
